Holen Sie sich die Stockscreener-App
3.87
1.78%
-0.07
Handel nachbörslich:
3.93
0.06
+1.55%
Schlusskurs vom Vortag:
$3.94
Offen:
$3.94
24-Stunden-Volumen:
1.02M
Relative Volume:
0.75
Marktkapitalisierung:
$331.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-36.95M
KGV:
-4.6071
EPS:
-0.84
Netto-Cashflow:
$-33.46M
1W Leistung:
-1.02%
1M Leistung:
+16.92%
6M Leistung:
+38.71%
1J Leistung:
-50.19%
1-Tages-Spanne:
$3.75
$3.95
1-Wochen-Bereich:
$3.59
$4.05
52-Wochen-Spanne:
$1.61
$9.50
Larimar Therapeutics Inc Stock (LRMR) Company Profile
Firmenname
Larimar Therapeutics Inc
Sektor
Branche
Telefon
844-511-9056
Adresse
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
Vergleichen Sie LRMR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRMR
Larimar Therapeutics Inc
|
3.87 | 317.54M | 0 | -36.95M | -33.46M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-29 | Eingeleitet | Truist | Buy |
| 2024-10-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-03 | Eingeleitet | Wedbush | Outperform |
| 2024-10-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-03 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-10-19 | Eingeleitet | Guggenheim | Buy |
| 2022-02-15 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-02-10 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-02-01 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Larimar Therapeutics Inc Aktie (LRMR) Neueste Nachrichten
Using fundamentals and technicals on Larimar Therapeutics Inc.Jobs Report & Weekly Breakout Opportunity Watchlist - Newser
Can a trend reversal in Larimar Therapeutics Inc. lead to recoveryWeekly Stock Analysis & Daily Entry Point Trade Alerts - Newser
Smart tools for monitoring Larimar Therapeutics Inc.’s price actionJuly 2025 Earnings & Trade Opportunity Analysis Reports - Newser
Can machine learning forecast Larimar Therapeutics Inc. recoveryMarket Movement Recap & Free Weekly Watchlist of Top Performers - Newser
Larimar Therapeutics Inc.’s volatility index tracking explainedWeekly Stock Report & Step-by-Step Swing Trade Plans - Newser
Published on: 2025-09-03 05:33:18 - Newser
Using data tools to time your Larimar Therapeutics Inc. exit2025 Fundamental Recap & Free Community Consensus Stock Picks - Newser
How hedge fund analytics apply to Larimar Therapeutics Inc. stockWeekly Trade Summary & Technical Pattern Based Signals - Newser
News impact scoring models applied to Larimar Therapeutics Inc.Weekly Loss Report & Fast Moving Trade Plans - Newser
Is Larimar Therapeutics Inc. still worth holding after the dipJuly 2025 Price Swings & High Accuracy Trade Signal Alerts - Newser
Analyzing recovery setups for Larimar Therapeutics Inc. investorsPortfolio Risk Summary & Daily Entry Point Alerts - Newser
How to integrate Larimar Therapeutics Inc. into portfolio analysis tools2025 Support & Resistance & Daily Profit Focused Stock Screening - Newser
Should you wait for a breakout in Larimar Therapeutics Inc.2025 Fundamental Recap & Free Community Consensus Stock Picks - Newser
Will Larimar Therapeutics Inc. stock recover after recent dropJuly 2025 PreEarnings & Consistent Profit Trading Strategies - Newser
Is Larimar Therapeutics Inc. forming a reversal patternJuly 2025 Short Interest & Weekly Top Performers Watchlists - Newser
Does Larimar Therapeutics Inc. have strong EBITDA marginsProfit Target & Step-by-Step Swing Trade Plans - khodrobank.com
Earnings visualization tools for Larimar Therapeutics Inc.Earnings Summary Report & Detailed Earnings Play Alerts - Newser
Applying Wyckoff theory to Larimar Therapeutics Inc. stock2025 Bull vs Bear & AI Forecasted Stock Moves - Newser
Is Larimar Therapeutics Inc. stock bottoming outWeekly Trade Analysis & Verified Momentum Watchlists - Newser
Is Larimar Therapeutics Inc.’s ROE strong enoughJuly 2025 Weekly Recap & Weekly Watchlist of Top Performers - khodrobank.com
What’s the RSI of Larimar Therapeutics Inc. stockJuly 2025 Volume & Weekly High Return Stock Forecasts - khodrobank.com
What are Larimar Therapeutics Inc.’s recent SEC filings showingWeekly Trading Summary & Expert Approved Trade Ideas - khodrobank.com
Using R and stats models for Larimar Therapeutics Inc. forecastingWeekly Profit Report & Community Verified Trade Signals - Newser
What analysts say about Larimar Therapeutics Inc. stock2025 Valuation Update & Weekly Watchlist for Consistent Profits - khodrobank.com
Is Larimar Therapeutics Inc. in a consolidation phase2025 Technical Overview & AI Powered Trade Plan Recommendations - khodrobank.com
Is Larimar Therapeutics Inc. stock a good pick for beginners2025 Growth vs Value & Accurate Intraday Trading Signals - khodrobank.com
What are Larimar Therapeutics Inc.’s growth leversJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - khodrobank.com
Published on: 2025-09-01 11:18:16 - Newser
Larimar Therapeutics price target lowered to $18 from $22 at Citizens JMP - MSN
Larimar Therapeutics’ SWOT analysis: nomlabofusp’s potential reshapes FA stock outlook - Investing.com
Larimar Therapeutics Inc. Price Targets Raised After Rebound getLinesFromResByArray error: size == 0 - kangso.co.kr
Larimar Therapeutics Advances Nomlabofusp Program Toward 2026 FDA Filing - MSN
Order flow analysis tools used on Larimar Therapeutics Inc.Earnings Trend Report & Capital Efficient Trade Techniques - Newser
Analysts Apply Wyckoff Model to Larimar Therapeutics Inc. Stock getLinesFromResByArray error: size == 0 - news-j.co.kr
Can Larimar Therapeutics Inc. Regain Momentum After BreakdownJuly 2025 Drop Watch & AI Powered Buy/Sell Recommendations - beatles.ru
Applying sector rotation models to Larimar Therapeutics Inc.Entry Point & Real-Time Buy Signal Alerts - Newser
Finanzdaten der Larimar Therapeutics Inc-Aktie (LRMR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):